{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:39:00Z","timestamp":1791279540718,"version":"4.1.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:p>Metabolic dysfunction associated fatty liver disease (MAFLD) was a concept suggested lately. Initially, the only criterion for the diagnosis of MAFLD was the absence of alcohol intake. With rising prevalence and studies assessing this condition, certain \u201cpositive criteria\u201d were put forth. Experts from 22 countries proposed a simple yet comprehensive definition for the condition independent of other liver diseases. The presence of hepatic steatosis in addition to diabetes mellitus type 2, metabolic dysregulation, and obesity is generally observed. Criteria to define MAFLD-associated cirrhosis were also proposed. Reaching an agreement on MAFLD criteria will help define a protocol (for example: for International classification of Diseases (ICD) - coding), which will improve clinical care and advance the clinical and scientific field of liver research. As it is a condition that increases the risk of diabetes mellitus, chronic kidney disease (CKD), cirrhosis, hepatocellular carcinoma, and cardiac disorders it is important to recognize it at an early stage which makes it essential part of family medicine and primary care.<\/jats:p>","DOI":"10.4103\/jfmpc.jfmpc_1863_21","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T02:02:04Z","timestamp":1721959324000},"page":"2857-2862","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Fatty liver disease - non alcoholic to metabolic - A transition of concepts!!"],"prefix":"10.4103","volume":"13","author":[{"given":"Nipun","family":"Bawiskar","sequence":"first","affiliation":[{"name":"Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research (Deemed to be University), Wardha, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourya","family":"Acharya","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research (Deemed to be University), Wardha, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research (Deemed to be University), Wardha, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,7,26]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD:A consensus-Driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH:Trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s13679-018-0317-8","article-title":"Epidemiology of obesity in adults:Latest trends","volume":"7","author":"Inoue","year":"2018","journal-title":"Curr Obes Rep"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020:The state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.29607","article-title":"Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science","volume":"67","author":"Siddiqui","year":"2018","journal-title":"Hepatology"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease:Practice guidance from the American Association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.29797","article-title":"Noninvasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials","volume":"68","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/oby.2010.174","article-title":"The prevalence of metabolically healthy obese subjects defined by BMI and dual-energy X-Ray absorptiometry","volume":"19","author":"Shea","year":"2011","journal-title":"Obesity"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/apt.15015","article-title":"The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity","volume":"48","author":"Ampuero","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohe-patitis among a largely middle-aged population utilizing ultrasound and liver biopsy:A prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/17474124.2019.1649981","article-title":"Concurrent nonalcoholic fatty liver disease and type 2 diabetes:Diagnostic and therapeutic consider-ations","volume":"13","author":"Arrese","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/apt.15015","article-title":"The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity","volume":"48","author":"Ampuero","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jhep.2013.04.027","article-title":"A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver","volume":"59","author":"Pais","year":"2013","journal-title":"J Hepatol"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-Term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease:Systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"R17-20240828","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrgastro.2013.149","article-title":"From NAFLD to NASH to cirrhosis \u2013new insights into disease mechanisms","volume":"10","author":"Wree","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD:A consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"R19-20240828","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ajg.2014.132","article-title":"Mortality from chronic liver diseases in diabetes","volume":"109","author":"Zoppini","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s00125-010-1663-6","article-title":"The impact of liver fat vs. visceral fat in determining categories of prediabetes","volume":"53","author":"Kantartzis","year":"2010","journal-title":"Diabetologia"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1681\/ASN.2009080820","article-title":"Mechanisms linking obesity, chronic kidney disease, and fatty liver disease:The roles of fetuin-A, adiponectin, and AMPK","volume":"21","author":"Ix","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R22-20240828","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/0003319714537872","article-title":"Association between nonalcoholic fatty liver disease and carotid artery inflammation evaluated by 18F-fluorodeoxyglucose positron emission tomography","volume":"66","author":"Moon","year":"2015","journal-title":"Angiology"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1161\/ATVBAHA.110.207340","article-title":"Serum gamma-glutamyl transferase and risk of heart failure in the community","volume":"30","author":"Dhingra","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R24-20240828","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.amjcard.2012.09.021","article-title":"Relation of circulating liver transaminase concentrations to risk of new-onset atrial fibrillation","volume":"111","author":"Sinner","year":"2013","journal-title":"Am J Cardiol"},{"key":"R25-20240828","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1042\/CS20130036","article-title":"Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes","volume":"125","author":"Targher","year":"2013","journal-title":"Clin Sci (Lond)"},{"key":"R26-20240828","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.2215\/CJN.05050610","article-title":"Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis","volume":"5","author":"Targher","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R27-20240828","first-page":"11788","article-title":"Very-low-carbohydrate ketogenic diet v. low-fat diet for long term eight loss:A meta analysis of randomised control led trials","volume":"110","author":"Bueno","year":"2013","journal-title":"Br J Nuts"},{"key":"R28-20240828","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/j.gastro.2009.01.048","article-title":"Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction","volume":"136","author":"Kirk","year":"2009","journal-title":"Gastroenterology"},{"key":"R29-20240828","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1002\/hep.26299","article-title":"Dietary fructose in nonalcoholic fatty liver disease","volume":"57","author":"Vos","year":"2013","journal-title":"Hepatology"},{"key":"R30-20240828","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jhep.2011.08.018","article-title":"Omega-3 supplementation and non-alcoholic fatty liver disease:A systematic review and meta-analysis","volume":"56","author":"Parker","year":"2012","journal-title":"J Hepatol"},{"key":"R31-20240828","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1053\/j.gastro.2020.01.051","article-title":"Therapeutic landscape for NAFLD in 2020","volume":"158","author":"Neuschwander-Tetri","year":"2020","journal-title":"Gastroenterology"},{"key":"R32-20240828","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic-fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"R33-20240828","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.3748\/wjg.v21.i13.3777","article-title":"Current pharmacological therapies for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"21","author":"Takahashi","year":"2015","journal-title":"World J Gastroenterol"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1863_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:58:20Z","timestamp":1787839100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1863_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,26]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1863_21","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,26]]},"assertion":[{"value":"2021-09-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}